The following sets forth the total stock-based compensation expense for employee equity plans included in the Company’s condensed consolidated statements of operations:


	Three Months Ended April 30,
	2026		2025
	(in thousands)
Cost of revenue	$	991	$	1,223
Research and development	5,432		8,614
Sales and marketing	1,882		3,079
General and administrative	2,290		4,947
Total stock-based compensation expense	$	10,595	$	17,863

As of April 30, 2026, the Company had unrecognized stock-based compensation expense related to RSUs and PRSUs (as defined below), and 2021 ESPP (as defined below) of $37.0 million, which is expected to be recognized over a weighted-average period of 1.9 years.

The 2021 Employee Stock Purchase Plan (“2021 ESPP”) permits participants to purchase shares of the Company’s Common Stock at a discounted price through payroll deductions. As of April 30, 2026, 894,753 shares of Common Stock were available under the 2021 ESPP.

The 2021 Equity Incentive Plan (“2021 EIP”) allows the Company to grant stock options, stock appreciation rights, restricted stock units (“RSUs”), performance restricted stock units (“PRSUs”), and certain other awards. As of April 30, 2026, 2,674,574 shares of Common Stock were available under the 2021 EIP.

A summary of RSUs outstanding under the 2021 EIP as of April 30, 2026 and changes during the fiscal year-to-date period then ended is presented in the following table, adjusted on a retroactive basis to reflect the Reverse Stock Split as discussed in Note 1, Description of Business and Basis of Presentation:


	Number of Shares	Weighted Average Grant Date Fair Value per Share
Outstanding as of January 31, 2026	2,195,297	$	26.56
RSU granted	26,601	$	6.38
RSU vested	(289,681)	$	41.19
RSU forfeited	(173,812)	$	26.95
Outstanding as of April 30, 2026	1,758,405	$	23.80

Pursuant to the 2021 EIP, the Company grants PRSUs to certain officers, including the Company’s Chief Executive Officer. Vesting of the PRSUs is dependent upon the satisfaction of both market- and service-based conditions occurring at the

end of a four- or five- year period. The market-based condition is achieved if the closing price of the Company’s Common Stock is greater than or equal to the applicable stock price appreciation target over a specified period at any time during the period beginning the date of the grant and ending on the expiration date.

Performance-based PRSUs are granted to certain employees, including executive officers, with vesting based on the achievement of specific financial goals, such as EBITDA. The grant date fair value of performance-based PRSUs are valued based on the Company’s stock price at the grant date. Stock-based compensation expense is recognized over the requisite service period based on the number of units expected to vest, which is reassessed during each reporting period based on the Company’s evaluation of the probability of achieving the applicable performance conditions.

A summary of PRSUs outstanding under the 2021 EIP as of April 30, 2026 and changes during the fiscal year-to-date period then ended is presented in the following table, adjusted on a retroactive basis to reflect the Reverse Stock Split as discussed in Note 1, Description of Business and Basis of Presentation:


	Number of Shares	Weighted Average Grant Date Fair Value per Share
Outstanding as of January 31, 2026	444,933	$	23.22
PRSUs granted	—	$	—

PRSU forfeited	—	$	—
Outstanding as of April 30, 2026	444,933	$	23.22

In fiscal year 2022, the Company terminated its 2017 Stock Option Plan (the “2017 Plan”) and 2007 Stock Option Plan (the “2007 Plan”).

A summary of options outstanding under the 2017 Plan and 2007 Plan as of April 30, 2026 and changes during the fiscal year-to-date period then ended is presented in the following table, adjusted on a retroactive basis to reflect the Reverse Stock Split as discussed in Note 1, Description of Business and Basis of Presentation:


	Number of Stock Option Awards	Weighted Average Exercise Price		Weighted Average Remaining Contractual term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of January 31, 2026	118,756	$	15.51	3.1	$	—

Options expired	(3,145)	$	12.67
Outstanding as of April 30, 2026	115,611	$	15.58	2.8	$	—
Options vested and expected to vest as of April 30, 2026	115,611	$	15.58	2.8	$	—
Exercisable as of April 30, 2026	115,611	$	15.58	2.8	$	—